54 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
. In addition, pursuant to Amendment No. 1 to the Gottesdiener Employment Agreement, Dr. Gottesdiener is entitled to reimbursement for commuting
8-K
EX-10.1
PRME
Prime Medicine Inc
5 Jan 24
Departure of Directors or Certain Officers
8:15am
schedule.
b.All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred … , but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount
S-3
EX-4.6
4oejz
3 Nov 23
Shelf registration
5:23pm
S-3
EX-4.5
5r83ospr6utfa6w14c
3 Nov 23
Shelf registration
5:23pm
S-3
ptkg0x jjtk
3 Nov 23
Shelf registration
5:23pm
DEFA14A
i5upx8skjip
11 May 23
Additional proxy soliciting materials
8:09am
8-K
6oobtf
11 May 23
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
nqlj6vh8474ugkrp
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
DEF 14A
ilnc0s7qe2ayq1k
28 Apr 23
Definitive proxy
8:34am
10-Q
mhwix1nx rgjh
14 Nov 22
Quarterly report
4:46pm
424B4
am240xhjy
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
3p2ft
13 Oct 22
IPO registration (amended)
10:51am
S-1/A
EX-10.1
ht3r 7k6bjjkc7
13 Oct 22
IPO registration (amended)
10:51am
S-1/A
EX-10.2
xuhdpc
13 Oct 22
IPO registration (amended)
10:51am